Internal Medicine, Hematology & Oncology · Tracy, CA
NPI
1003241118
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2200 Orchard Pkwy Ste 102
Tracy, CA, 95377
Phone (209) 830-4060
Groups this clinician bills Medicare through
Medicare paid, 2022
$12K
976 services
Medicare patients, 2022
12
Average age 63
Drug cost, 2024
$8.2M
1,700 prescriptions
Company payments, 2025
$385
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Yu Cheng prescribed most often to Medicare patients was Hydroxyurea, with 256 prescriptions and refills. In total Yu Cheng wrote 1,700 Medicare prescriptions that cost $8.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydroxyurea Generic | 256 | 611 | 79 | $9,544 |
| Lenalidomide Generic | 209 | 209 | 33 | $2.6M |
| Dexamethasone Generic | 145 | 173 | 34 | $1,873 |
| Brukinsa Zanubrutinib | 97 | 97 | 11 | $1.2M |
| Alvaiz Eltrombopag Choline | 93 | 93 | 14 | $691K |
| Acyclovir Generic | 77 | 217 | 39 | $2,243 |
| Jakafi Ruxolitinib Phosphate | 69 | 69 | Under 11 | $1.0M |
| Pomalyst Pomalidomide | 59 | 59 | Under 11 | $1.5M |
| Prednisone Generic | 39 | 71 | 20 | $523 |
| Allopurinol Generic | 32 | 60 | 19 | $266 |
| Imatinib Mesylate Generic | 31 | 50 | Under 11 | $2,370 |
| Ondansetron Hcl Generic | 30 | 32 | 21 | $344 |
| Calquence Acalabrutinib Maleate | 27 | 27 | Under 11 | $291K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | 19 | $1,143 |
| Gengraf Cyclosporine, Modified | 26 | 33 | Under 11 | $5,249 |
Brand drugs: 485 claims; generic drugs: 1,215 claims; opioid claims: 58.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yu Cheng $385 ($385 in general payments such as food, travel and fees) from 7 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $122.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.